Source: Pharmabiz

Biomerica: UAE health ministry approves Biomerica's Fortel PSA Screening Test to detect an early sign of prostate cancer

Biomerica, Inc., a global provider of innovative diagnostic solutions, announced that its Fortel Prostate Specific Antigen (PSA) Screening Test has received approval from the United Arab Emirates Ministry of Health and Prevention (MOHAP).

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Zackary Irani's photo - CEO of Biomerica

CEO

Zackary Irani

CEO Approval Rating

91/100

Read more